Bull NVAX - novavax 150 dollar targetI am looking for a 150 dollar target on Novavax but not invested in this since my bank (Handelsbanken) don't supply this.
NVV1 trade ideas
Novavax Set to Soar: A Bullish Breakout in Sight?Unveiling the Potential of NVAX
Novavax (NVAX), a notable biopharmaceutical stock, has witnessed a dramatic journey, plunging from its February 2021 high of approximately $330 to a critical low of $3.53 in February 2024. While this decline may appear daunting, our technical analysis suggests that it marks the completion of a triple WXYXZ corrective structure. This extended basing phase, in our view, sets the stage for a significant bullish breakout.
The Path Forward
From the $3.53 low, we foresee a powerful resurgence, initially targeting $75, with the possibility of reclaiming its historic $300+ levels. The recent impulsive patterns support the notion of an uptrend reversal, bolstered by improving market sentiment within the sector.
A Key Level to Watch
It’s imperative to note that the $3.53 level serves as a critical invalidation point for our bullish outlook. A revisit of this level would nullify the current scenario, signalling a continuation of the downtrend.
Conclusion
Novavax embodies a high-risk, high-reward opportunity for discerning investors. With technical indicators pointing to a bullish resurgence, now may be the time to watch closely. However, prudence is advised—implementing strict risk management is key as NVAX embarks on its potential recovery journey.
Stay informed, and monitor Novavax as it navigates this critical turning point.
$NVAX #nvax $24 target by 12/9/2024Novavax, NASDAQ:NVAX phase 3 trial begins on 12/9/2024. ctv.veeva.com A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine
$NVAX $24 Dec 9, 2024NASDAQ:NVAX Novavax stock, $24 on 12/9/24. ctv.veeva.com Phase 3 trial begins on Monday, Dec. 9, 2024. Squeezing.
Novavax Inc (Extended Hours) | Chart & Forecast SummaryKey Indicators On Trade Set Up In General
1. Push Set Up
2. Range Set up
3. Break & Retest Set Up
Notes On Session
# Novavax Inc (Extended Hours)
- Double Formation
* Retracement Template 50%| Short Set Up | Subdivision 1
* Wedge Structure | A+ Set Up | At Area 23.80 | Subdivision 2
- Triple Formation
* Support=0 | Wedge Structure
* 012345 | Subdivision 3
* Retracement Area | 0.382
Active Sessions On Relevant Range & Elemented Probabilities;
London(Upwards) - NYC(Downwards)
Conclusion | Trade Plan Execution & Risk Management On Demand;
Overall Consensus | Neutral
NVAX will make us happy soon.1) RSI 2 moving averages will cross each other soon. Purple one 38.14 and Green one 38.69. If purple one cut above green one it will be buy sign. I am waiting for buying next year because this is monthly chart. I hope RSI's 2 moving averages will cross each other. 36.91, 35.21 and 31.72 were very important support line in the past and it reversed from this level.
2) Momentum is reaching 0 line. If it is less than 0, it shows that down trend. If it is more than 0, it shows that upper trend. Of course NVAX decreased a lot but Momentum is trying to exceed 0 line up. If Momentum is reaching 0 line from minus, it means that down trend is losing its power and it will be reversal of trend.
3) DMI indicator has 3 moving averages inside of it. ADX is red one and it shows that trend's power not direction. If it is less than 20, it means that this is sideways market. It will be more than 20 in the future. Now it is 16.2284. If ADX is more than 20, it shows that this security has strong trend. It can be upper or down trend, we cannot know. We have to check out prices or Momentum indicator.
4) It is not certain but can work why not. Target Price = Minimum 168. Maximum 330. Because i calculated like that: (Highest level of prices + Lowest level of prices)/2 = Target Price
ALL COMMENTS DO NOT İNCLUDE INVESTING ADVICE!
NVAX, is prepping for a turnaround ERA. Massive Growth Prospect!NVAX surged an impressive 29.4% last trading day with significant volume. Net positive volume increased massively from 6.33M to 28.12M for a 344% increase. These extraordinary numbers should be telling of what's to come in the mid to long term.
Buyers are back in the scene, positioning at the current price range in anticipation of growth prospect both in technical and fundamental aspect.
On our monthly data, some big shifts are happening. On histogram, the stock recorded its third straight shifted lines -- these lines came out after 3.5 years of waiting. Similarly, a fresh bubble up volume re-appeared after a series of descend over the years. This is giving us a lowkey clue already of the intended direction.
It is now sitting a 1.0 FIB level, this is beyond bargain / discount already. The stock is hovering around a 4-year longstanding strong support. Expect some upside price valuation to materialize in the next coming weeks.
All these 'shifts' are conveying a turnaround prospect for NVAX.
Spotted at 9.0
TAYOR.
Safeguard capital always
NVAX at the crossroadNVAX had some headwinds news with the small set back on the 2nd stage clinical trial. The 15% drop landed the NVAX at the bottom of the trend line, a confirmed break below low (below 10$ for 2+ trading days) would be a strong sell signal, or a potential rebounded to the up trendline with more support of debunking the allegation.
Buy it!Novavax ...with the most recent collaboration with SNY Sanofi bolstering the stock price to $26.. I initiated a position at $12.66..
The cash on hand is 1.3B, Debt 2.5B..
I ll be buying all dips...hopefully down to $6/share... I initiated a position because of the FOMO factor.
NFA
The NVAX 2nd Wave Has Just Begun I will be following this one very closely. Today's price action is very alarming having jumped over 20% on the day as volume reached 17 M vs its 6M daily average.
I plan on capitalizing on the hype and volatility that this stock generates and will be sharing some thoughts on the lower time frames.
Current price sits at 14.68$.
Targets lie at 15.90$, 17$, 22.50$ and possibly higher 👀
Strategic Approach: Waiting for the Next Signal Cycle on NovavaxNovavax (NVAX) has already experienced a notable uptrend, and I'm taking a cautious approach. I plan to wait for the next signal cycle before considering any additional purchases. This strategy will help ensure I'm making informed decisions based on market movements.
Where I think we are with NVAX chart & and where we might goThis is what I see. I think the NVAX chart is very bullish. I'm anticipating a FIB retracement in the coming months. Who knows if this will actually play out, of course, but it's what I'm looking for.
NVAX eyes on $ 13.99: Golden Genesis fib, Do or Die levelNVAX has been testing a Golden Genesis fib.
Look for a clear rejection or Break-n-Retest.
Break to continue recovery or reject to DOOM.
=========================================
.
Novavax Printing a Clear Bull Flag | We've Seen This BeforeIn my previous idea, I showed how the NVAX chart had completed a textbook Wyckoff accumulation schematic, and the resulting big move upward into the "sign of strength" phase was almost exactly as predicted.
As of today, we've just about completed a textbook Wyckoff "sign of strength" phase. The last time we saw this same style bull flag on the Novavax chart, the price quickly shot up more than 1,700% before consolidating and making another big move upward.
NVAX - Novavax, Inc.Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Watchlist: NVAXNVAX is now on my watchlist for tomorrow. I got a setup signal and with above average volume . Looking to enter if the stock can manage to close above the last candle highs with a stop-loss below and a price target above.
$NVAX incoming $44.32Novavax, incoming possible $44.32 target due to head and shoulders pattern and falling wedge.
NVAX target $44.32 by September 2024NVAX inverse head and shoulders target of $44.32 by September 2024? Weekly projected chart coming off right shoulder with targets.
NVAX falling wedge projection of $25.59Novovax falling wedge target projection of $25.59 based on projections using $3.81 in April 2024 and $23.86 from June 2024
NVAX listed on Nasdaq. I bought these shares at the very bottomNVAX listed on Nasdaq. I bought these shares at the very bottom. I made a take profit at the price of 16. Now we have a correction and I expect a drop to the price of 5.05 and there I will buy shares of this company
NVAX: Continuity of the upward trendOn NVAX we would have a continuity of the upward trend with regard to the configuration on the chart. We have the vwap indicator as well as the resistance line which have been broken with force.
